248 related articles for article (PubMed ID: 17119886)
41. The role of sentinel lymph node biopsy in patients with local recurrence or in-transit metastasis of melanoma.
Gipponi M; Solari N; Giovinazzo D; Queirolo P; Bertoglio S; Villa G; Gualco M; Bleidl D; Cafiero F
Anticancer Res; 2014 Jun; 34(6):3197-203. PubMed ID: 24922694
[TBL] [Abstract][Full Text] [Related]
42. Sentinel lymph node biopsy for gastrointestinal cancers.
Bembenek A; Gretschel S; Schlag PM
J Surg Oncol; 2007 Sep; 96(4):342-52. PubMed ID: 17726666
[TBL] [Abstract][Full Text] [Related]
43. [Sentinel lymph node biopsy in gastro-intestinal surgery: facts and future implications].
Pocard M; Sabourin JC
J Chir (Paris); 2008 Dec; 145 Spec no. 4():12S17-12S20. PubMed ID: 19194353
[TBL] [Abstract][Full Text] [Related]
44. Disseminated tumor cells in the bone marrow negatively influence survival after resection of colorectal liver metastases.
Hinz S; Bockhorst J; Röder C; Egberts JH; Schafmayer C; Küchler T; Becker T; Kalthoff H
Ann Surg Oncol; 2012 Aug; 19(8):2539-46. PubMed ID: 22395998
[TBL] [Abstract][Full Text] [Related]
45. [The sentinel navigation surgery: current review and future perspective].
Tajima T; Tokuda Y; Yasuda S
Nihon Rinsho; 2002 Jan; 60(1):197-205. PubMed ID: 11808334
[TBL] [Abstract][Full Text] [Related]
46. [Long-term results of sentinel node biopsy diagnostics in penile carcinoma : Dynamic sentinel node biopsy in cases with nonpalpable lymph nodes in the groin].
Naumann CM; Bothe K; Munk-Hartig AK; van der Horst C; Massad H; Lützen U; Jünemann KP; Hamann MF
Urologe A; 2016 May; 55(5):641-4. PubMed ID: 26450095
[TBL] [Abstract][Full Text] [Related]
47. Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients.
Mittendorf EA; Sahin AA; Tucker SL; Meric-Bernstam F; Yi M; Nayeemuddin KM; Babiera GV; Ross MI; Feig BW; Kuerer HM; Hunt KK
Ann Surg Oncol; 2008 Dec; 15(12):3369-77. PubMed ID: 18815841
[TBL] [Abstract][Full Text] [Related]
48. [Clinical significance of isolated tumor cells and micrometastases in patients with gastric carcinoma].
Kodera Y; Nakanishi H; Ito S; Nakao A
Gan To Kagaku Ryoho; 2007 Jun; 34(6):817-23. PubMed ID: 17565240
[TBL] [Abstract][Full Text] [Related]
49. The impact of method of biopsy on the incidence of breast cancer sentinel lymph node metastases.
Meattini I; Giannotti E; Abdulcadir D; Saieva C; Guerrieri AM; Vanzi E; Scartoni D; Cecchini S; Sanchez LJ; Orzalesi L; Casella D; Bianchi S; Livi L; Nori J
Eur J Surg Oncol; 2014 Mar; 40(3):277-81. PubMed ID: 24388742
[TBL] [Abstract][Full Text] [Related]
50. [A decade of sentinel lymph node biopsy for breast cancer: time for adaptations].
Wobbes T
Ned Tijdschr Geneeskd; 2008 Jan; 152(1):10-2. PubMed ID: 18240753
[TBL] [Abstract][Full Text] [Related]
51. Detection of minimal residual disease in lung cancer.
Chudacek J; Bohanes T; Klein J; Benedikova A; Srovnal J; Szkorupa M; Skalicky P; Skarda J; Hajduch M; Neoral C
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Jun; 158(2):189-93. PubMed ID: 23558472
[TBL] [Abstract][Full Text] [Related]
52. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
53. Biological ablation of sentinel lymph node metastasis in submucosally invaded early gastrointestinal cancer.
Kikuchi S; Kishimoto H; Tazawa H; Hashimoto Y; Kuroda S; Nishizaki M; Nagasaka T; Shirakawa Y; Kagawa S; Urata Y; Hoffman RM; Fujiwara T
Mol Ther; 2015 Mar; 23(3):501-9. PubMed ID: 25523761
[TBL] [Abstract][Full Text] [Related]
54. Predicting axillary sentinel node status in patients with primary breast cancer.
Kolarik D; Pecha V; Skovajsova M; Zahumensky J; Trnkova M; Petruzelka L; Halaska M; Sottner O; Otcenasek M; Kolarova H
Neoplasma; 2013; 60(3):334-42. PubMed ID: 23374005
[TBL] [Abstract][Full Text] [Related]
55. Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells.
Pepels MJ; de Boer M; Bult P; van Dijck JA; van Deurzen CH; Menke-Pluymers MB; van Diest PJ; Borm GF; Tjan-Heijnen VC
Ann Surg; 2012 Jan; 255(1):116-21. PubMed ID: 22183034
[TBL] [Abstract][Full Text] [Related]
56. Detection of minimal residual disease in patients with cancer: a review of techniques, clinical implications, and emerging therapeutic consequences.
Köstler WJ; Brodowicz T; Hejna M; Wiltschke C; Zielinski CC
Cancer Detect Prev; 2000; 24(4):376-403. PubMed ID: 11059569
[TBL] [Abstract][Full Text] [Related]
57. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
[TBL] [Abstract][Full Text] [Related]
58. Circulating tumor cells and circulating tumor DNA: What surgical oncologists need to know?
Cabel L; Proudhon C; Mariani P; Tzanis D; Beinse G; Bieche I; Pierga JY; Bidard FC
Eur J Surg Oncol; 2017 May; 43(5):949-962. PubMed ID: 28185687
[TBL] [Abstract][Full Text] [Related]
59. Detection of disseminated tumor cells: strategies and diagnostic implications.
Zehentner BK
Expert Rev Mol Diagn; 2002 Jan; 2(1):41-8. PubMed ID: 11963801
[TBL] [Abstract][Full Text] [Related]
60. Prediction of non-SN involvement in patients with SN isolated tumor cells or micrometastases.
Pesce C; Balch C; Jacobs L
Breast Dis; 2010; 31(2):99-106. PubMed ID: 21368372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
